UBS/PUT/PFIZER INC/33/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 12:30:11 2024-07-03 EDT | ||
| 0.5 EUR | +4.17% |
|
| Current month | +6.38% | ||
| 1 month | +31.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 0.5 | +4.17% |
| 24-07-02 | 0.48 | +6.67% |
| 24-07-01 | 0.45 | -4.26% |
| 24-06-28 | 0.47 | -6.00% |
| 24-06-27 | 0.5 | -3.85% |
Delayed Quote Deutsche Boerse AG
Last update July 03, 2024 at 12:30 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | UBS |
| WKN | UL3318 |
| ISIN | CH1280725628 |
| Date issued | 2023-07-11 |
| Strike | 33 $ |
| Maturity | 2024-09-20 (79 Days) |
| Parity | 10 : 1 |
| Emission price | 0.23 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.76 € |
|---|---|
| Lowest since issue | 0.151 € |
| Spread | 0.05 € |
| Spread % | 9.09% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7
USD
Average target price
31.92
USD
Spread / Average Target
+15.22%
- Stock Market
- Warrants
- Warrant
